Cidara Therapeutics, Inc. (CDTX)

220.96 +0.10 (+0.04%) USD  |  NASDAQ  |  Dec 24, 12:32
More

Cidara Therapeutics CAPEX To Revenue (TTM)

CAPEX To Revenue (TTM) Chart

View CAPEX To Revenue (TTM) for CDTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View CAPEX To Revenue (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

CAPEX To Revenue (TTM) Range, Past 5 Years

View CAPEX To Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

CAPEX To Revenue (TTM) Benchmarks

View CAPEX To Revenue (TTM) Benchmarks
Start Trial
Merck & Co., Inc. Upgrade
Mersana Therapeutics, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
Johnson & Johnson Upgrade
Pfizer Inc. Upgrade